(1S,4R,5E,7S,10Z,20S,21S)-4-ethyl-17-hydroxy-7-[(1S)-1-hydroxy-3-methylbut-2-enyl]-10,21-dimethyl-8,24,26-trioxa-14-azatetracyclo[13.8.2.11,20.019,25]hexacosa-5,10,15,17,19(25)-pentaene-9,13,22-trione

Details

Top
Internal ID aef9fbf7-e4c2-4ac9-923c-fdc9babbd9a5
Taxonomy Phenylpropanoids and polyketides > Macrolactams
IUPAC Name (1S,4R,5E,7S,10Z,20S,21S)-4-ethyl-17-hydroxy-7-[(1S)-1-hydroxy-3-methylbut-2-enyl]-10,21-dimethyl-8,24,26-trioxa-14-azatetracyclo[13.8.2.11,20.019,25]hexacosa-5,10,15,17,19(25)-pentaene-9,13,22-trione
SMILES (Canonical) CCC1CCC23CC(=O)C(C(O2)C4=C(O3)C(=CC(=C4)O)NC(=O)CC=C(C(=O)OC(C=C1)C(C=C(C)C)O)C)C
SMILES (Isomeric) CC[C@@H]\1CC[C@]23CC(=O)[C@H]([C@H](O2)C4=C(O3)C(=CC(=C4)O)NC(=O)C/C=C(\C(=O)O[C@@H](/C=C1)[C@H](C=C(C)C)O)/C)C
InChI InChI=1S/C31H39NO8/c1-6-20-8-9-26(24(34)13-17(2)3)38-30(37)18(4)7-10-27(36)32-23-15-21(33)14-22-28-19(5)25(35)16-31(39-28,12-11-20)40-29(22)23/h7-9,13-15,19-20,24,26,28,33-34H,6,10-12,16H2,1-5H3,(H,32,36)/b9-8+,18-7-/t19-,20+,24+,26+,28+,31+/m1/s1
InChI Key NXQKNJIQGBLGMU-XVYITHGISA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C31H39NO8
Molecular Weight 553.60 g/mol
Exact Mass 553.26756720 g/mol
Topological Polar Surface Area (TPSA) 131.00 Ų
XlogP 4.00
Atomic LogP (AlogP) 5.04
H-Bond Acceptor 8
H-Bond Donor 3
Rotatable Bonds 3

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1S,4R,5E,7S,10Z,20S,21S)-4-ethyl-17-hydroxy-7-[(1S)-1-hydroxy-3-methylbut-2-enyl]-10,21-dimethyl-8,24,26-trioxa-14-azatetracyclo[13.8.2.11,20.019,25]hexacosa-5,10,15,17,19(25)-pentaene-9,13,22-trione

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9287 92.87%
Caco-2 - 0.8240 82.40%
Blood Brain Barrier - 0.5500 55.00%
Human oral bioavailability - 0.5857 58.57%
Subcellular localzation Mitochondria 0.5204 52.04%
OATP2B1 inhibitior - 0.8575 85.75%
OATP1B1 inhibitior + 0.8234 82.34%
OATP1B3 inhibitior + 0.9155 91.55%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.8572 85.72%
BSEP inhibitior + 0.9843 98.43%
P-glycoprotein inhibitior + 0.8326 83.26%
P-glycoprotein substrate + 0.6820 68.20%
CYP3A4 substrate + 0.7024 70.24%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8852 88.52%
CYP3A4 inhibition - 0.6769 67.69%
CYP2C9 inhibition - 0.7943 79.43%
CYP2C19 inhibition - 0.7423 74.23%
CYP2D6 inhibition - 0.9218 92.18%
CYP1A2 inhibition - 0.7727 77.27%
CYP2C8 inhibition + 0.6751 67.51%
CYP inhibitory promiscuity - 0.7345 73.45%
UGT catelyzed - 0.7000 70.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.5192 51.92%
Eye corrosion - 0.9885 98.85%
Eye irritation - 0.9533 95.33%
Skin irritation - 0.7696 76.96%
Skin corrosion - 0.9311 93.11%
Ames mutagenesis - 0.6328 63.28%
Human Ether-a-go-go-Related Gene inhibition - 0.4113 41.13%
Micronuclear + 0.7300 73.00%
Hepatotoxicity - 0.5089 50.89%
skin sensitisation - 0.8209 82.09%
Respiratory toxicity + 0.6889 68.89%
Reproductive toxicity + 0.9000 90.00%
Mitochondrial toxicity + 0.8375 83.75%
Nephrotoxicity - 0.6936 69.36%
Acute Oral Toxicity (c) III 0.6697 66.97%
Estrogen receptor binding + 0.8067 80.67%
Androgen receptor binding + 0.7380 73.80%
Thyroid receptor binding + 0.5247 52.47%
Glucocorticoid receptor binding + 0.8204 82.04%
Aromatase binding - 0.5000 50.00%
PPAR gamma + 0.7360 73.60%
Honey bee toxicity - 0.7390 73.90%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.5600 56.00%
Fish aquatic toxicity + 0.9187 91.87%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 99.24% 98.95%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.79% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 98.01% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.87% 96.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 95.18% 95.56%
CHEMBL1937 Q92769 Histone deacetylase 2 94.50% 94.75%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 92.87% 85.14%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 92.56% 93.40%
CHEMBL1806 P11388 DNA topoisomerase II alpha 92.49% 89.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 90.93% 97.09%
CHEMBL325 Q13547 Histone deacetylase 1 90.77% 95.92%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.94% 94.45%
CHEMBL3310 Q96DB2 Histone deacetylase 11 89.07% 88.56%
CHEMBL5103 Q969S8 Histone deacetylase 10 86.80% 90.08%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 86.42% 93.03%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 85.74% 99.23%
CHEMBL3401 O75469 Pregnane X receptor 85.35% 94.73%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.09% 95.89%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 83.50% 97.14%
CHEMBL1994 P08235 Mineralocorticoid receptor 82.75% 100.00%
CHEMBL2069156 Q14145 Kelch-like ECH-associated protein 1 82.55% 82.38%
CHEMBL4208 P20618 Proteasome component C5 82.24% 90.00%
CHEMBL236 P41143 Delta opioid receptor 80.96% 99.35%
CHEMBL1902 P62942 FK506-binding protein 1A 80.80% 97.05%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 80.31% 95.89%
CHEMBL4657 Q6V1X1 Dipeptidyl peptidase VIII 80.16% 97.21%

Cross-Links

Top
PubChem 53235715
NPASS NPC143008